Yeah I was a bit surprised at that too. Might follow it up later. Best case is the inference is that those pharma are returning to PYC eg Genentech but worst case is he has misunderstood. I think they point he is trying to make is that each partnership progressed the science to a more valuable proposition that is still progressing towards a financial outcome.
The lack of a wider following here on HC is still a great indication that so few know about this story. As soon as 1 broker (Euroz) started covering it demand picked up - imagine when the story is more broadly told.
PYC for smarties, page-12
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 11.0¢ | 10.0¢ | $184.6K | 1.761M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 51807 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 680221 | 5 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |